Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atrandi’s SPC-based platforms enable scalable single-cell multiomic analyses with high throughput. Their products are installed in over 200 labs worldwide as of early 2025. The company has launched proof-of-concept programs demonstrating the ability to barcode up to ~10k microbial genomes per experiment at low cost ($1/cell), supporting advances in microbial community analysis and oncology diagnostics through collaborative projects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atrandi Biosciences.